Vertex Pharmaceuticals Inc. buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€382.55
Target price
07.05.26
-
Performance (%)
-2.00%
Price
17.04.26
€374.90
Summary
This prediction is currently active. With a performance of -2.00%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 07.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.739% | 0.739% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "buy" rating re-affirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for VRTX provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€397.35
31.01.24
31.01.24
€515.17
31.01.25
31.01.25
11.04%
01.02.25
01.02.25
